$16.620
-0.294 (-1.77%)Zum Schluss
IART-News
IART-Events
Integra LifeSciences Q2 Revenue $418.8M, Exceeds Expectations
Reports Q2 revenue $418.8M, consensus $417.54M. "Our Q2 performance reflects meaningful progress on our most important priorities. We are improving supply reliability, advancing quality, and returning products to market with discipline. The Braintree facility is now producing and ramping to support the planned SurgiMend relaunch later this year," said Stuart Essig, Chairman and CEO of Integra LifeSciences. "At the same time, we are seeing the benefits of a more aligned commercial organization while we continue to reduce our balance sheet leverage. Supported by our broad portfolio, attractive markets, and focused leadership team, we are strengthening our operating foundation and enhancing our ability to deliver sustainable long-term shareholder value."
Lowers FY26 Revenue Outlook to $1.654B-$1.695B
Lowers FY26 revenue view to $1.654B-$1.695B from $1.662B-$1.702B to reflect the impact of a stronger U.S. dollar on foreign exchange rates. Consensus is for FY26 revenue $1.68B.
Company Sees Q3 Revenue of $410M-$425M
Sees Q3 revenue $410M-$425M, consensus $417.43M. Q3 revenue view represents a reported growth of 2.0%-5.7% and organic growth of 1.9%-5.7%.
Integra LifeSciences Appoints Topaz Kirlew as Chief Regulatory Officer
Integra LifeSciences announced the appointment of Topaz Kirlew as corporate vice president and chief regulatory officer. Kirlew will lead Integra's global regulatory affairs organization and oversee regulatory strategy, compliance, submissions, and transformation initiatives worldwide. Kirlew served as the interim regulatory leader for the company over the past several months, leading the global regulatory organization during an important period for the company. In her interim capacity, she provided oversight of regulatory compliance, managed active submissions, and led risk mitigation efforts across the organization.
U.S. Futures Rise as Oil Prices Pull Back
Futures are pointing higher this morning as oil pulls back from recent spikes. Crude had surged above $110-$120 on escalating U.S.-Iran conflict headlines, but is now easing and the 10-year yield is stabilizing around the mid-4% range.Earnings remain strong and AI capital expenditures continue to act as a structural tailwind. There is persistent capital flow into semis and hyperscalers, with expectations for massive multi-year spend cycles anchoring estimates higher. Under the surface, dispersion remains high. Strong prints are still being rewarded while weaker forward visibility is getting punished.In pre-market trading, S&P 500 futures rose 0.44%, Nasdaq futures rose 0.73% and Dow futures rose 0.36%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -Intelup 4% after BloombergApplehas held discussions on using Intel and Samsungto produce the main processors for its U.S. devicesUP AFTER EARNINGS -Pinterestup 18%Integra LifeSciencesup 10%Watersup 10%Rockwell Automationup 9%AB InBevup 6%DuPontup 2%Cumminsup 2%KKRup 1%GlobalFoundriesup 1%Archer Danielsup 1%Leidosup 1%DOWN AFTER EARNINGS -Fabrinetdown 12%Fiservdown 9%PayPaldown 8%Shopifydown 6%On Semidown 6%Eatondown 4%Duolingodown 4%Palantirdown 1%
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.